MedTrace Logo

Real Life Study in Myopic Neovascularization

NCT03797547 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 24

Last updated 2021-09-29

No results posted yet for this study

Summary

This is a multi centre, single arm, prospective observational phase 4 study in naive or pretreated patients with myopic neovascularization. The patients will be treated with intravitreal injections of Aflibercept following a real life protocol.

This sudy aims to evaluate the visual acuity during a 36 months period of time.

Conditions

  • Myopic Choroidal Neovascularisation

Interventions

OTHER

AFLIBERCEPT

Patients will be treated following a real life protocol and according to the French recommendation

Sponsors & Collaborators

  • Poitiers University Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-22
Primary Completion
2023-01-30
Completion
2023-01-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03797547 on ClinicalTrials.gov